Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07651631 · ClinicalTrials.gov registry record
Rapid Evacuation and Access of Cerebral Hemorrhage Registry
A clinical trial, sponsored by Emory University.
- Not yet
- Registry status
- 2,500
- Enrollment target
NCT07651631: Clinical Trial study, sponsored by Emory University.
NCT07651631 is a clinical trial that has not yet begun recruiting, run by Emory University. The registered enrollment target is 2,500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07651631 has not yet begun recruiting, sponsored by Emory University.
- NOT YET RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
Study Summary
The goal of this observational study is to quantify the real-world effect of minimally invasive surgery (MIS) in patients with acute spontaneous supratentorial intracerebral hemorrhage.
Primary Outcome
Functional outcome will be assessed using the modified Rankin Scale (mRS), a 7-level ordinal scale ranging from 0 (no symptoms) to 6 (death). The primary endpoint evaluates real-world functional recovery following minimally invasive surgery (MIS) for acute supratentorial ICH. Structured interview performed in person or via telephone by trained study personnel; audio-recorded and centrally adjudicated.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2026-06 |
| Est. Completion | 2033-06 |
What is known before NCT07651631 opens enrollment
NCT07651631 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT07651631 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07651631 about?
NCT07651631 is a clinical study titled "Rapid Evacuation and Access of Cerebral Hemorrhage Registry". The goal of this observational study is to quantify the real-world effect of minimally invasive surgery (MIS) in patients with acute spontaneous supratentorial intracerebral hemorrhage.
What is the current status of trial NCT07651631?
This trial is currently not yet recruiting. The enrollment target is 2,500 participants. The study started on 2026-06. Estimated completion is 2033-06.
Who is sponsoring clinical trial NCT07651631?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia